mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.056 |
0.7 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.062 |
0.7 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |